CUSIP 69012T305COMOTLKQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
52 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Schonfeld Strategic Advisors LLC | 2.44M | $3.86M | +1.73M | Added |
| 2 | Vanguard Group Inc | 1.47M | $2.31M | +122.5K | Added |
| 3 | Blackrock, Inc. | 404.5K | $639.2K | +34.8K | Added |
| 4 | Gilpin Wealth Management, LLC | 354.2K | $559.6K |
| +354.2K |
| New Position |
| 5 | Geode Capital Management, LLC | 316.5K | $500.1K | +10.2K | Added |
| 6 | Marshall Wace, LLP | 298.5K | $471.6K | +298.5K | New |
| 7 | Ubs Group AG | 209.5K | $331.1K | +161.4K | Added |
| 8 | Susquehanna International Group, LLP | 172.0K | $271.8K | −39.4K | Reduced |
| 9 | Millennium Management LLC | 164.5K | $259.9K | −30.1K | Reduced |
| 10 | State Street Corp | 163.1K | $257.7K | +87.8K | Added |
See every fund holding Outlook Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders